Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, targeted treatment for non-small cell lung cancer (NSCLC). The German pharma ...
Station Identification, aka Station ID or Legal ID, is scheduled in automation to play at the top of every hour between programs. Recorded programs do not need to include a Legal ID because it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback